Mitochondria-associated endoplasmic reticulum membranes (MAMs)

Mitochondria-associated endoplasmic reticulum membranes (MAMs) are specialized subcellular domains where the endoplasmic reticulum (ER) and outer mitochondrial membrane (OMM) come into close physical proximity (typically 10–100 nm) without undergoing membrane fusion [1, 6]. They function as a critical signaling hub and material exchange platform, coordinating essential cellular processes such as calcium transfer, phospholipid and cholesterol synthesis, mitochondrial dynamics, and the initiation of autophagy and apoptosis [4, 8]. MAMs are maintained by specific protein tethering complexes, most notably the IP3R-GRP75-VDAC1 complex, which facilitates the rapid flux of calcium from the ER to the mitochondrial matrix to drive oxidative phosphorylation or trigger cell death pathways [2, 11]. Dysregulation of MAM integrity—characterized by either excessive tethering leading to mitochondrial calcium overload or insufficient contact causing metabolic failure—is a hallmark of various pathologies, including Alzheimer's disease, Type 2 diabetes, and heart failure [12, 14]. Therapeutic strategies currently focus on modulating MAM-resident proteins, such as the Sigma-1 receptor or Mitofusin-2, to restore proper organelle communication and cellular homeostasis [13, 15]. Pharmacological agents like Sigma-1 agonists (e.g., PRE-084) and chemical chaperones (e.g., 4-PBA) are under investigation for their ability to stabilize these contact sites and mitigate the progression of neurodegenerative and metabolic disorders [11, 15].

Other names

Mitochondria-associated ER membranesMAMER-mitochondria contact sitesERMCSMitochondria-ER contactsMERCs

Modulation of ER-mitochondria tethering; regulation of calcium flux through the IP3R-GRP75-VDAC1 complex; stabilization of lipid transfer; suppression of ER stress-mediated pathways.